MedTrace Logo

The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic Rhinitis

NCT00688441 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 453

Last updated 2010-08-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effect of nasal carbon dioxide in the treatment of Seasonal Allergic Rhinitis

Conditions

  • Seasonal Allergic Rhinitis

Interventions

DRUG

Nasal CO2

Twice daily during the 14 day Treatment Period

DRUG

Placebo

Use of the study drug dispenser at the same frequency as the active arm

Sponsors & Collaborators

  • Capnia, Inc.

    lead INDUSTRY

Principal Investigators

  • S. David Miller, MD · Northeast Medical Research Associates, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2008-10-31
Completion
2008-11-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00688441 on ClinicalTrials.gov